
Abhishek Pandey is a highly respected expert in Abbvie's global research efforts. He has played a crucial role in advancing the company's scientific understanding and developing innovative treatments.
With a strong background in research, Abhishek has been instrumental in driving Abbvie's research agenda forward. His expertise has been invaluable in shaping the company's global research strategy.
Abhishek's dedication to Abbvie's research has been recognized through his various roles within the organization.
Intriguing read: Abbvie Company Profile
Global Lead Research Scientist
Abhishek Pandey is the Global Lead and Principal Research Scientist II at AbbVie, specializing in Machine Learning for Drug Discovery.
He leads a team of machine learning scientists focused on developing advanced Machine Learning methods for various aspects of drug discovery.
Abhishek holds a Ph.D. in Electrical and Computer Engineering from the University of Arizona.
Prior to joining AbbVie, Abhishek was a founding member of the AI team at Tempus Labs Inc, now known as Tempus AI.
Explore further: Abbvie Executives
Research Approach
Abhishek Pandey's team at AbbVie is focused on developing advanced machine learning algorithms for Discovery, Developmental Sciences, and the AbbVie-Calico alliance departments.
Abhishek Pandey leads a team of machine learning scientists at AbbVie, specializing in Machine Learning for Drug Discovery. His team's work spans cheminformatics, imaging research, multi-omics, and the computation behind many of AbbVie's current partnerships and collaborations.
Abhishek's team at AbbVie is responsible for developing state-of-the-art machine learning algorithms for Discovery, Developmental Sciences, and the AbbVie-Calico alliance departments.
The team's work includes developing PADME (Protein And Drug Molecule interaction prEdiction), a framework based on Deep Neural Networks, to predict real-valued interaction strength between compounds and proteins.
Abhishek Pandey's team at AbbVie is making significant contributions to the field of machine learning for drug discovery.
Here are some key areas where Abhishek's team is making an impact:
- Target identification and prioritization
- ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity)
- De Novo design of molecule
- Tox (Toxicity)
- Precision medicine
By developing these advanced machine learning algorithms, Abhishek's team is helping AbbVie streamline its drug discovery process and bring new treatments to market more efficiently.
Frequently Asked Questions
Who is the current CEO of AbbVie?
The current CEO of AbbVie is Rob Michael, who also serves as Chairman of the Board.
Featured Images: pexels.com


